Clario Selects Cognizant as Global Strategic Technology Services Provider

The collaboration will help Clario advance its employee and customer offerings in support of its mission to transform lives by generating high-quality evidence for more informed decision making.

“At Clario, we pride ourselves on providing the best technology for our customers and we do that by creating a robust and innovative ecosystem,” said Jay Ferro, EVP, Chief Information, Technology & Product Officer at Clario. “Cognizant’s innovative technology and industry expertise made them the natural choice to partner on the next phase of our digital transformation journey.”

Clario develops digital solutions that redefine possibilities in clinical trials by enhancing the accuracy, reliability, speed, and efficiency of data gathering and analysis. Over the course of the five-year relationship, Clario will leverage Cognizant’s experience in automation and digital technologies for process and experience modernisation, supporting:

–Achieving faster time to market by streamlining workflows and enhancing collaboration across teams.
–Building a foundation for a digital enterprise by integrating data, analytics, and AI capabilities across the company.
–Driving cutting edge innovation in the clinical trials space by adopting agile methodologies and best practices.

“Clinical trials require secure and reliable technology to manage patient data, monitor results, ensure regulations are met, and more.” said Cognizant’s Mohammad Haque, SVP, Global Large Deals Lead and BU Head, Life Sciences. “Clario is doing groundbreaking work in providing this technology to run clinical trials, and Cognizant is excited to work alongside them to modernise their offerings.”